This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm.
This is just horrible news.
Today the FDA issued a distrubing warning of an association between the drug Actos and bladder cancer. The warning comes after a review of data from a five-year analysis of an ongoing study of Actos by its manufacturer, Takeda Pharmaceuticals. The results show that there was an increased risk of bladder cancer among those who had used the drug the longest. There was also a greater risk of bladder cancer among Actos users who had been exposed to the highest cumulative dose of the drug. The FDA has issued a new warning of increased bladder cancer risk associated with use of Actos.
As many of my readers are aware, I sadly lost my dear father to cancer in April 2010. It angers me to no end that a company would put patients at risk for such a devastating illness like cancer. Rest assured that I will be actively pursuing this case and will seek justice for those injured.
If you or someone you know has taken Actos and been diagnosed with bladder cancer, please contact me toll-free, 24 hours a day, for a free, no-obligation evaluation of your claim.
 
About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.